Oragenics Inc (AMEX:OGEN)’s traded shares stood at 0.54 million during the last session, with the company’s beta value hitting 0.44. At the close of trading, the stock’s price was $0.37, to imply an increase of 2.75% or $0.01 in intraday trading. The OGEN share’s 52-week high remains $7.74, putting it -1991.89% down since that peak but still an impressive 32.43% since price per share fell to its 52-week low of $0.25. The company has a valuation of $4.51M, with an average of 0.29 million shares in intraday trading volume over the past 10 days and average of 478.36K shares over the past 3 months.

Oragenics Inc (AMEX:OGEN) trade information

After registering a 2.75% upside in the last session, Oragenics Inc (OGEN) has traded red over the past five days. The 5-day price performance for the stock is 16.26%, and 17.74% over 30 days. With these gigs, the year-to-date price performance is -93.43%. Short interest in Oragenics Inc (AMEX:OGEN) saw shorts transact 0.19 million shares and set a 0.43 days time to cover.

OGEN Dividends

Oragenics Inc has its next earnings report out in January. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.

Oragenics Inc (AMEX:OGEN)’s Major holders

Oragenics Inc insiders hold 25.41% of total outstanding shares, with institutional holders owning 11.13% of the shares at 14.92% float percentage. In total, 11.13% institutions holds shares in the company.